跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gelofusine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gelofusine
Approved
STANDARD
Gelofusine
B. Braun Medical Industries Sdn. Bhd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d301d4168f7ed90d
Company
B. Braun Medical Industries Sdn. Bhd.
Type
Standard
Approval Details
Approval Id
d301d4168f7ed90d
Drug Approval Philippines Name
Gelofusine
Product Name
Gelofusine
Registration Number
DR-XY23955
Brand Name
Gelofusine
Generic Name
Modified Fluid Gelatin
Dosage Form
Intravenous Infusion
Dosage Strength
4% (4g/ 100mL)
Manufacturer
B. Braun Medical Industries Sdn. Bhd.
Importer
B.BRAUN MEDICAL SUPPLIES, INC.
Company Detail Path
/organization/b-braun-medical-industries-sdn-bhd
Issuance Date
12 April 2023
Expiry Date
11 March 2028
Pharmacologic Category
Blood Substitute and Plasma Protein Fraction
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d301d4168f7ed90d
Type
Standard
Back to Philippines FDA Approvals